Cancer is characterized by the aberrant utilization of normal cellular signal transduction pathways. Hemopoietic cells require growth factors for their self-renewal and differentiation. Interleukin-3 (IL-3) is a cytokine secreted by activated T cells which supports the growth of hemopoietic precursor cells. Using non-transformed IL3-dependent murine cell lines, which represent early hemopoietic cells, we have isolated factor-independent transformants which are tumorigenic. Unlike the parental cells, the factor-independent cells secreted IL-3, were rearranged at the IL-3 locus, and overexpressed the IL-3 receptor. Therefore, we proposed they were transformed by an autocrine mechanism. The goal of this proposal is to delineate the mechanisms by which these and similar hemopoietic cells are rendered malignant. To accomplish this objective, the following specific aims are proposed:
Aim 1. To determine the mechanism of activation of IL-3 expression, Aim 2. To determine whether IL-3 gene rearrangement is sufficient to transform cells to factor-independence, Aim 3. To determine whether increased expression of the IL-3 receptor is associated with transformation, and Aim 4. To determine the mechanisms by which spontaneous, chemical and chronic retroviral infection can activate IL-3 gene expression.
Aim l. will test the hypothesis that transposition of an intracisternal type A particle to the 3' side of the IL-3 locus acts either as an enhancer or displaces DNA sequences implicated in mRNA stability, thereby prolonging IL-3 expression.
Aim 2. will test the hypothesis that rearrangement of the IL-3 gene enables factor-dependent cells to grow in the absence of exogenous IL-3 and also results in malignant transformation.
Aim 3. will test the hypothesis, that in concert with the increased expression of the IL-3 gene, upregulation of the cognate receptor is often necessary for autocrine transformation, Aim 4. will test the hypothesis that abrogation of factor-dependency often occurs as the result of insertional mutagenesis. An understanding of the mechanisms of IL-3 gene activation and rearrangement, which occurs in some murine factor-dependent cells and human acute lymphocytic leukemias, may aid in the pathogenesis, prevention and treatment of hemopoietic malignancies and will provide insights into the mechanisms of regulation of normal and abnormal cellular growth.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA051025-03
Application #
2094070
Study Section
Pathology B Study Section (PTHB)
Project Start
1992-07-01
Project End
1996-05-31
Budget Start
1994-06-01
Budget End
1995-05-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
East Carolina University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Greenville
State
NC
Country
United States
Zip Code
27858
Lehmann, Brian D; Paine, Matthew S; Brooks, Adam M et al. (2008) Senescence-associated exosome release from human prostate cancer cells. Cancer Res 68:7864-71
Franklin, Richard A; McCubrey, James A (2007) Polyphenols in breast cancer treatment. Cancer Biol Ther 6:62-3
McCubrey, James A; Franklin, Richard A (2006) Reactive oxygen intermediates and signaling through kinase pathways. Antioxid Redox Signal 8:1745-8
Franklin, Richard A; Rodriguez-Mora, Oswaldo G; Lahair, Michelle M et al. (2006) Activation of the calcium/calmodulin-dependent protein kinases as a consequence of oxidative stress. Antioxid Redox Signal 8:1807-17
Lahair, Michelle M; Howe, Christopher J; Rodriguez-Mora, Oswaldo et al. (2006) Molecular pathways leading to oxidative stress-induced phosphorylation of Akt. Antioxid Redox Signal 8:1749-56
McCubrey, James A; Lahair, Michelle M; Franklin, Richard A (2006) Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8:1775-89
Rodriguez-Mora, Oswaldo G; Lahair, Michelle M; Evans, Mark J et al. (2006) Inhibition of the CaM-kinases augments cell death in response to oxygen radicals and oxygen radical inducing cancer therapies in MCF-7 human breast cancer cells. Cancer Biol Ther 5:1022-30
McCubrey, James A; Lahair, Michelle M; Franklin, Richard A (2006) OSU-03012 in the treatment of glioblastoma. Mol Pharmacol 70:437-9
Konopleva, Marina; Shi, Yuexi; Steelman, Linda S et al. (2005) Development of a conditional in vivo model to evaluate the efficacy of small molecule inhibitors for the treatment of Raf-transformed hematopoietic cells. Cancer Res 65:9962-70
Rodriguez-Mora, Oswaldo G; LaHair, Michelle M; McCubrey, James A et al. (2005) Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res 65:5408-16

Showing the most recent 10 out of 64 publications